Medicare Enrolled
Dr. Steven Golombek, M.D.
Rheumatology · Dover, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Golombek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Golombek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Golombek
Dr. Steven Golombek is a rheumatology specialist in Dover, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Golombek performed 419,341 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Golombek received a total of $381,452 from 24 pharmaceutical and/or device companies across 718 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Golombek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 1% volume in NJ
$381,452 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗419,341
Medicare services
Top 1% in NJ for rheumatology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
181,800 | $4 | $10 |
| Tocilizumab injection (Actemra) | 118,880 | $5 | $10 |
| Denosumab injection (Prolia/Xgeva) | 42,360 | $18 | $30 |
| Romosozumab injection (Evenity) for osteoporosis | 17,640 | $8 | $15 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
16,985 | $33 | $75 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
14,200 | $11 | $30 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
8,310 | $26 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,816 | $99 | $175 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
2,381 | $66 | $150 |
| Infliximab-abda biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
2,190 | $35 | $125 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
1,950 | $62 | $150 |
| Methotrexate sodium, 50 mg | 1,665 | $2 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,497 | $72 | $150 |
| Joint lubricant injection (Synvisc) | 1,104 | $7 | $20 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
805 | $120 | $275 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
747 | $60 | $132 |
| Orthovisc intra-articular injection An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
610 | $96 | $750 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
591 | $26 | $150 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
577 | $1 | $30 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
447 | $49 | $100 |
| Injection, methylprednisolone acetate, 40 mg | 346 | $6 | $40 |
| New patient office visit, complex (60-74 min) | 240 | $173 | $300 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
222 | $34 | $40 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
198 | $73 | $75 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
189 | $59 | $400 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
112 | $45 | $125 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
95 | $7 | $200 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
90 | $39 | $128 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
83 | $89 | $461 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
39 | $9 | $41 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
36 | $9 | $30 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
28 | $31 | $55 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
27 | $33 | $75 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
27 | $4 | $100 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
24 | $26 | $125 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
19 | $59 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $128 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.8% high complexity
88.5% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$381,452
Total received (2018-2024)
Avg $54,493/year across 7 years
Top 2% in NJ for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
718
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$31,636
2023
$32,279
2022
$36,548
2021
$26,016
2020
$45,330
2019
$109,088
2018
$100,555
Payments by company (2024)
Amgen Inc.
$20,699
AstraZeneca Pharmaceuticals LP
$10,501
Novartis Pharmaceuticals Corporation
$240
UCB, Inc.
$93
Fresenius Kabi USA, LLC
$49
ANI Pharmaceuticals, Inc.
$19
PFIZER INC.
$18
Genentech USA, Inc.
$16
Top 3 companies account for 99.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$234,412
AstraZeneca Pharmaceuticals LP
$48,634
GENZYME CORPORATION
$41,081
Horizon Pharma plc
$15,700
Horizon Therapeutics plc
$15,300
Novartis Pharmaceuticals Corporation
$9,126
Celgene Corporation
$5,553
Regeneron Healthcare Solutions, Inc.
$5,030
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,163
Fresenius Kabi USA, LLC
$1,249
GlaxoSmithKline, LLC.
$542
E.R. Squibb & Sons, L.L.C.
$492
Genentech USA, Inc.
$287
UCB, Inc.
$284
SANOFI-AVENTIS U.S. LLC
$198
Cardinal Health 110 LLC
$100
PFIZER INC.
$77
Lilly USA, LLC
$56
Janssen Biotech, Inc.
$41
Organon LLC
$33
AbbVie, Inc.
$29
Merck Sharp & Dohme Corporation
$28
ANI Pharmaceuticals, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$17
Top 3 companies account for 85.0% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · Humira · IDACIO · ILARIS · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · NUCALA · OFEV · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · RENFLEXIS · Rituxan · SAPHNELO · SEGLENTIS · SIMPONI ARIA · STELARA · TALTZ · TAVNEOS · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
81
County median income
$134,929
Nearest hospital to ZIP centroid (approximate)
SAINT CLARE'S HOSPITAL/ DENVILLE CAMPUS
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Golombek is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Golombek experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Golombek performed 181,800 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Golombek receive payments from pharmaceutical companies?
Yes. Dr. Golombek received a total of $381,452 from 24 companies across 718 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Golombek's costs compare to other rheumatologists in Dover?
Dr. Golombek's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Golombek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Dover
Browse rheumatologists in Dover ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NJ
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NJ
Which NJ rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology